수젠텍

253840KOSDAQ의료용품 및 기타 의약 관련제품 제조업

49.0 / 100

Reference Date: 2026-04-13

Financial Score17.5 / 40

News Sentiment17.5 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 9.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

SuneTech develops and commercializes diagnostic technologies and products in multiplex immuno blot, point-of-care testing (POCT), digital healthcare, and health & beauty sectors, leveraging BIO/NANO/IT/A.I convergence. The company is expanding into personalized healthcare services and FemTech, utilizing diagnostic data for customized health and beauty solutions such as functional foods and cosmetics.

Number of Employees

153people

Average Salary

49.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

1.01Industry Average 1.625.5Point

Lower than industry avg (good)

ROE

-27.03Industry Average -4.893.5Point

5.5x industry avg (excellent)

Debt Ratio

21.45Industry Average 8.880.0Point

2.4x industry avg (risky)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.4% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲8.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -18.5% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Positive
캐나다 기업과 제휴…수젠텍, '만성질환 진단시장' 조준
수젠텍은 캐나다의 응급·현장진단 전문기업 '리스폰스 바이오메디컬(RBM)'과 차세대 신속 진단 플랫폼의 글로벌 상용화를 위한 전략적 파트너십을 체결했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 4,605Won52-week high 8,78052-week low 4,490

1-month return1.0Point

1m -8.99% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-08
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral사업보고서 (2025.12)2026-03-18
Neutral감사보고서제출2026-03-18